Patents by Inventor Dezhong WANG

Dezhong WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Riding-type mower and current-limiting protection method thereof
    Patent number: 11942807
    Abstract: A riding-type mower includes a power supply device and the power supply device includes a plurality of battery packs and a power management module. The plurality of battery packs are detachably mounted to the riding-type mower and further configured to supply electric energy to a hand-held electric power tool. The plurality of battery packs each are provide with at least one battery cell group, and each battery cell group includes a plurality of battery cells electrically connected to each other. The power management module is configured to determine whether the plurality of battery packs satisfy a discharge condition and control a battery pack satisfying the discharge condition to discharge when the battery pack satisfies the discharge condition.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: March 26, 2024
    Assignee: Nanjing Chervon Industry Co., Ltd.
    Inventors: Lei Wang, Dezhong Yang
  • Nucleoside phosphoramidate compound and use thereof
    Patent number: 9963480
    Abstract: A novel nucleoside phosphoramidate compound of the formula below, or a stereoisomer, salt, hydrate, solvate or crystal thereof for the treatment of Flaviviridae family viral infection, especially hepatitis C viral infection, and having a good anti-HCV effect; a pharmaceutical composition having the compound, or a stereoisomer, salt, hydrate, solvate or crystal thereof:
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: May 8, 2018
    Assignee: NANJING SANHOME PHARMACEUTICAL CO., LTD.
    Inventors: Yong Wang, Liwen Zhao, Xian Zhang, Sheng Bi, Yiping Gao, Hongyan Chen, Dezhong Wang, Yang Nan, Cang Zhang, Yuxiu Li, Di Zhang
  • 9,9,10,10-Tetrafluoro-9,10-dihydrophenanthrene hepatitis C virus inhibitor and application thereof
    Patent number: 9512108
    Abstract: The present invention belongs to the field of chemical pharmaceuticals, and specifically relates to compounds represented by formula I having a 9,9,10,10-tetrafluoro-9,10-dihydrophenanthrene structure and being able to inhibit hepatitis C virus activity, or a pharmaceutically acceptable salt, isomer, solvate, crystal or prodrug of said compounds, a pharmaceutical composition containing said compounds, and an application of said compounds or composition in the preparation of a drug. The compounds of the present invention have a good HCV inhibitory effect.
    Type: Grant
    Filed: December 26, 2014
    Date of Patent: December 6, 2016
    Assignee: NANJING SANHOME PHARMACEUTICAL CO., LTD.
    Inventors: Yong Wang, Liwen Zhao, Dezhong Wang, Haiping Zhou, Xian Zhang, Hongyan Chen, Di Zhang, Cang Zhang
  • 9,9,10,10-TETRAFLUORO-9,10-DIHYDROPHENANTHRENE HEPATITIS C VIRUS INHIBITOR AND APPLICATION THEREOF
    Publication number: 20160297804
    Abstract: The present invention belongs to the field of chemical pharmaceuticals, and specifically relates to compounds represented by formula I having a 9,9,10,10-tetrafluoro-9,10-dihydrophenanthrene structure and being able to inhibit hepatitis C virus activity, or a pharmaceutically acceptable salt, isomer, solvate, crystal or prodrug of said compounds, a pharmaceutical composition containing said compounds, and an application of said compounds or composition in the preparation of a drug. The compounds of the present invention have a good HCV inhibitory effect.
    Type: Application
    Filed: December 26, 2014
    Publication date: October 13, 2016
    Applicant: NANJING SANHOME PHARMACEUTICAL CO., LTD.
    Inventors: Yong WANG, Liwen ZHAO, Dezhong WANG, Haiping ZHOU, Xian ZHANG, Hongyan CHEN, Di ZHANG, Cang ZHANG
  • NOVEL NUCLEOSIDE PHOSPHORAMIDATE COMPOUND AND USE THEREOF
    Publication number: 20150361123
    Abstract: A novel nucleoside phosphoramidate compound, or a stereoisomer, salt, hydrate, solvate or crystal thereof for the treatment of Flaviviridae family viral infection, especially hepatitis C viral infection is provided. The pharmaceutical composition having the compound, or a stereoisomer, salt, hydrate, solvate or crystal thereof and a use of the compound or the composition in the treatment of Flaviviridae family viral infection, especially hepatitis C viral infection. The compound has a good anti-HCV effect.
    Type: Application
    Filed: March 6, 2014
    Publication date: December 17, 2015
    Applicant: NANJING SANHOME PHARMACEUTICAL CO., LTD
    Inventors: Yong WANG, Liwen ZHAO, Xian ZHANG, Sheng BI, Yiping GAO, Hongyan CHEN, Dezhong WANG, Yang NAN, Cang ZHANG, Yuxiu LI, Di ZHANG